{"id":8252,"date":"2020-08-21T13:24:10","date_gmt":"2020-08-21T17:24:10","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/companies-move-to-late-stage-covid-19-vaccine-trials\/"},"modified":"2020-08-21T13:24:10","modified_gmt":"2020-08-21T17:24:10","slug":"sirketler-gec-asama-covid-19-asi-denemelerine-geciyor","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/article\/sirketler-gec-asama-covid-19-asi-denemelerine-geciyor\/","title":{"rendered":"\u015eirketler Ge\u00e7 A\u015fama COVID-19 A\u015f\u0131 Denemelerine Ge\u00e7iyor"},"content":{"rendered":"<p>Pfizer ve Moderna&#039;dan y\u00f6neticiler, 2020&#039;nin sonuna kadar raflarda bir COVID-19 a\u015f\u0131s\u0131 bulundurma yolunda olduklar\u0131n\u0131 s\u00f6yl\u00fcyorlar.<\/p>\n<p>Her biri yakla\u015f\u0131k 30.000 hastan\u0131n olaca\u011f\u0131 bu iki denemeyle, <u><a href=\"https:\/\/www.reuters.com\/article\/us-health-coronavirus-moderna\/moderna-covid-19-vaccine-could-be-ready-for-use-by-end-of-year-u-s-says-idUSKCN24S18Z\" target=\"_blank\" rel=\"noopener\">Moderna ve Pfizer<\/a><\/u> a\u015f\u0131 geli\u015ftirme yar\u0131\u015f\u0131nda \u00f6nemli bir liderlik elde etti.<\/p>\n<p>\u015eu anda yakla\u015f\u0131k 150 firman\u0131n \u00e7e\u015fitli geli\u015ftirme a\u015famalar\u0131nda COVID-19 a\u015f\u0131lar\u0131 var.<\/p>\n<p>AstraZeneca, bu yaz ge\u00e7 a\u015fama denemelerine ba\u015flamay\u0131 umdu\u011funu s\u00f6yledi ve Johnson &amp; Johnson, Eyl\u00fcl ay\u0131na kadar bu a\u015famaya ula\u015faca\u011f\u0131n\u0131 tahmin etti.<\/p>\n<p>Ulusal Sa\u011fl\u0131k Enstit\u00fcleri (NIH) Direkt\u00f6r\u00fc Francis Collins, &quot;2020&#039;nin sonuna kadar da\u011f\u0131t\u0131lan g\u00fcvenli ve etkili bir a\u015f\u0131ya sahip olmak zorlu bir hedef&quot; dedi. Ancak, &quot;Amerikan halk\u0131 i\u00e7in do\u011fru hedef&quot; diye ekledi.<\/p>\n<h2>A\u015f\u0131 Pandemiyi Bitirir mi?<\/h2>\n<p>Etkili bir a\u015f\u0131, salg\u0131n\u0131n daha erken sona ermesine yard\u0131mc\u0131 olabilir.<\/p>\n<p>Vir\u00fcs a\u015f\u0131lar\u0131 genellikle enfeksiyon oran\u0131n\u0131 yakla\u015f\u0131k olarak azalt\u0131r. <u><a href=\"https:\/\/www.cdc.gov\/flu\/vaccines-work\/vaccineeffect.htm\" target=\"_blank\" rel=\"noopener\">y\u00fczde 50<\/a><\/u>. E\u011fer b\u00f6yle bir ara\u00e7 mevcut ve g\u00fcvenli ise kullan\u0131lmal\u0131d\u0131r.<\/p>\n<p>Ek olarak, a\u015f\u0131lar semptomlar\u0131 azalt\u0131r.<\/p>\n<p>A\u015f\u0131lanan hastalar enfekte olduklar\u0131nda genellikle eskisi kadar hasta olmazlar. Bu semptom azaltma, enfeksiyon oran\u0131n\u0131 daha da azaltmaya yard\u0131mc\u0131 olur.<\/p>\n<p>Ayr\u0131ca semptomlar\u0131n azalt\u0131lmas\u0131 \u00f6zellikle ya\u015fl\u0131 yeti\u015fkinler, \u00f6nceden belirli solunum rahats\u0131zl\u0131klar\u0131 olan ki\u015filer ve COVID-19&#039;un ya\u015fam\u0131 tehdit etti\u011fi ki\u015filer aras\u0131nda \u00f6nemlidir.<\/p>\n<p>Son olarak, a\u015f\u0131lar tipik olarak \u00f6nemli bir plasebo etkisine sahiptir.<\/p>\n<h2>COVID-19 A\u015f\u0131s\u0131 G\u00fcvenlik Sorunlar\u0131<\/h2>\n<p>ABD&#039;li bula\u015f\u0131c\u0131 hastal\u0131k doktoru Anthony Fauci, potansiyel bir a\u015f\u0131n\u0131n g\u00fcvenli\u011fi konusunda &quot;pek endi\u015feli olmad\u0131\u011f\u0131n\u0131&quot; s\u00f6yledi.<\/p>\n<p>Bu tam olarak \u00e7\u0131nlayan bir onay de\u011fil.<\/p>\n<p>Moderna daha \u00f6nce hi\u00e7 a\u015f\u0131 yapmam\u0131\u015ft\u0131 ve Pfizer hi\u00e7bir zaman kan\u0131tlanmam\u0131\u015f sentetik haberci RNA platformuna g\u00fcvenmedi.<\/p>\n<p>Tipik olarak, a\u015f\u0131lar v\u00fccuda \u00e7ok az miktarda vir\u00fcs enjekte eder, b\u00f6ylece v\u00fccut do\u011fal ba\u011f\u0131\u015f\u0131kl\u0131k \u00fcretir.<\/p>\n<p>mRNA farkl\u0131d\u0131r. Bu son derece karma\u015f\u0131k s\u00fcre\u00e7, h\u00fccre DNA&#039;s\u0131n\u0131 de\u011fi\u015ftirir ve par\u00e7ac\u0131klar\u0131 h\u00fccrenin d\u0131\u015f\u0131na ta\u015f\u0131r. Revize edilmi\u015f DNA sarmal\u0131 h\u00fccrenin sitoplazmas\u0131na girdi\u011finde, hastal\u0131k antikorlar\u0131n\u0131n yerine ge\u00e7en belirli proteinlerin \u00fcretimini tetikler.<\/p>\n<p>Bu s\u00fcrecin bir\u00e7ok hareketli par\u00e7as\u0131 vard\u0131r. Sonu\u00e7 olarak yap\u0131labilecek bir\u00e7ok \u015fey var. <u><a href=\"\/tr\/uygulama-alanlari-2\/ilac-davasi\/\">yanl\u0131\u015f gitmek<\/a><\/u>.<\/p>\n<p>Baz\u0131 g\u00f6zlemciler bu s\u00fcrecin ba\u015f d\u00f6nd\u00fcr\u00fcc\u00fc h\u0131z\u0131ndan endi\u015fe duyuyorlar. A\u015fa\u011f\u0131da bununla ilgili daha fazla bilgi.<\/p>\n<p>Ayr\u0131ca, kural olarak, h\u00fccre DNA&#039;s\u0131n\u0131 de\u011fi\u015ftirmek \u00e7ok riskli bir \u00f6nermedir. Ba\u015fta asbest olmak \u00fczere \u00e7e\u015fitli \u00e7evresel toksinler kansere ve di\u011fer ciddi hastal\u0131klara bu \u015fekilde neden olur.<\/p>\n<p>H\u0131zland\u0131r\u0131lm\u0131\u015f bir geli\u015ftirme zaman \u00e7izelgesinde, ara\u015ft\u0131rmac\u0131lar neredeyse kesinlikle t\u00fcm bu alternatifleri tam olarak ke\u015ffedemeyeceklerdir.<\/p>\n<p>Bu, ilk hastalar\u0131n kobay oldu\u011fu anlam\u0131na gelmez, ancak muhtemelen o mahallededir.<\/p>\n<h2>\u0130la\u00e7 \u00dcreticisinin Sorumlulu\u011fu<\/h2>\n<p>Pfizer, ABD h\u00fck\u00fcmetiyle $2 milyara elli milyon a\u015f\u0131 satmak i\u00e7in bir anla\u015fma imzalad\u0131 bile.<\/p>\n<p>Ayr\u0131ca Moderna, a\u015f\u0131s\u0131n\u0131n ileri a\u015fama klinik deneylere girdi\u011fini a\u00e7\u0131klad\u0131\u011f\u0131nda, hisse senedi fiyat\u0131 y\u00fczde 9 artt\u0131. Yani, bu iki \u015firket i\u00e7in ve \u00f6nce bir a\u015f\u0131 geli\u015ftirmek i\u00e7in yar\u0131\u015fan di\u011fer herkes i\u00e7in \u00e7ok fazla para s\u00f6z konusu.<\/p>\n<p>Bu yar\u0131\u015fmada ikinciye teselli \u00f6d\u00fcl\u00fc verilmemektedir. Kazanan hepsini al\u0131r.<\/p>\n<p>bu <u><a href=\"https:\/\/www.fda.gov\/patients\/fast-track-breakthrough-therapy-accelerated-approval-priority-review\/fast-track\" target=\"_blank\" rel=\"noopener\">H\u0131zl\u0131 par\u00e7a<\/a><\/u> h\u0131zland\u0131r\u0131lm\u0131\u015f onay s\u00fcreci yeni de\u011fil ve daha \u00f6nce ele\u015ftiri ya\u011fmuruna tutuldu.<\/p>\n<p>Yeni bir ila\u00e7 veya cihaz kar\u015f\u0131lanmam\u0131\u015f bir ihtiyaca hitap ederse, G\u0131da ve \u0130la\u00e7 \u0130daresi onay s\u00fcrecini \u00f6nemli \u00f6l\u00e7\u00fcde k\u0131salt\u0131r.<\/p>\n<p>Ek olarak, d\u00fczenleyiciler genellikle yeni ilac\u0131n g\u00fcvenli\u011fine odaklanmazlar. Bunun yerine, onu mevcut \u00fcr\u00fcnlerle kar\u015f\u0131la\u015ft\u0131r\u0131rlar.<\/p>\n<p>Ve e\u011fer yeni ila\u00e7, genellikle \u015firketin sa\u011flad\u0131\u011f\u0131 kan\u0131tlara dayanan bir geli\u015fmeyse, FDA normalde bunu onaylar.<\/p>\n<p>Fast Track onay\u0131 genellikle kanser, koronavir\u00fcs, AIDS ve benzeri di\u011fer durumlar i\u00e7in ayr\u0131lm\u0131\u015ft\u0131r.<\/p>\n<p>Bununla birlikte, FDA ayr\u0131ca depresyon, epilepsi ve diyabet gibi hastal\u0131klar\u0131 &quot;ciddi durumlar&quot; olarak tan\u0131mlar. Bu nedenle, neredeyse her yeni ila\u00e7 Fast Track onay\u0131na hak kazanabilir.<\/p>\n<p>Kusurlu bir ila\u00e7 veya cihaz piyasaya s\u00fcr\u00fcl\u00fcrse, ila\u00e7 \u00fcreticisi sonu\u00e7ta ortaya \u00e7\u0131kan yaralanmalardan kesinlikle sorumludur.<\/p>\n<p>Kusurlu ila\u00e7 iddialar\u0131nda, bir New York ki\u015fisel yaralanma avukat\u0131 normalde ila\u00e7 ile yan etki aras\u0131nda bir ba\u011flant\u0131 kurmak i\u00e7in alandaki en iyi uzmanlarla ortak \u00e7al\u0131\u015f\u0131r.<\/p>\n<p>K\u00f6t\u00fc haber \u015fu ki, ila\u00e7 \u015firketinin, ilac\u0131n g\u00fcvenli oldu\u011funa kolayca tan\u0131kl\u0131k eden bir s\u00fcr\u00fc uzman\u0131 var.<\/p>\n<p>\u0130yi haber \u015fu ki, kan\u0131tlama y\u00fck\u00fc (kan\u0131t\u0131n \u00fcst\u00fcnl\u00fc\u011f\u00fc veya olmamas\u0131ndan daha muhtemel) d\u00fc\u015f\u00fck.<\/p>\n<p>Di\u011fer iyi haber ise, New York&#039;un bilirki\u015fi de\u011ferlendirme standard\u0131n\u0131n kurban dostu olmas\u0131.<\/p>\n<p>Yak\u0131nda bir koronavir\u00fcs a\u015f\u0131s\u0131 bulunabilir, ancak kullan\u0131m i\u00e7in g\u00fcvenli olacak m\u0131? Bir avukatla \u00fccretsiz hukuki dan\u0131\u015fmanl\u0131k almak i\u00e7in <u><a href=\"\/tr\/bize-ulasin\/\">deneyimli New York ki\u015fisel yaralanma avukat\u0131<\/a><\/u>, contact Napoli Shkolnik .<\/p>","protected":false},"excerpt":{"rendered":"<p>Pfizer ve Moderna&#039;dan y\u00f6neticiler, 2020&#039;nin sonuna kadar raflarda bir COVID-19 a\u015f\u0131s\u0131 bulundurma yolunda olduklar\u0131n\u0131 s\u00f6yl\u00fcyorlar.<\/p>","protected":false},"author":3,"featured_media":8253,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[792],"tags":[953,964,971,992,993],"class_list":["post-8252","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-coronavirus","tag-medical-malpractice","tag-personal-injury","tag-health-and-safety","tag-coronavirus","tag-covid-19"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/8252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/comments?post=8252"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/8252\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media\/8253"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=8252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/categories?post=8252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/tags?post=8252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}